0.00Open0.00Pre Close0 Volume0 Open Interest15.00Strike Price0.00Turnover302.58%IV-68.54%PremiumJul 19, 2024Expiry Date6.10Intrinsic Value100Multiplier12DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7368Delta0.0649Gamma1.33Leverage Ratio-0.0628Theta-0.0039Rho-0.98Eff Leverage0.0055Vega
Profound Medical Stock Discussion
NEWS
Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum
Profound Medical Corp.'s TULSA procedure is gaining recognition as a mainstream treatment for prostate diseases, with 25 scientific research presentations this year alone. The clinical evidence showcases TULSA's efficacy in treating a diverse range of patients with localized prostate c...
No comment yet